Adial Pharmaceuticals

Home » Adial Pharmaceuticals

IPO

Adial Pharmaceuticals

They are a clinical-stage biopharmaceutical company focused on the development of a therapeutic agent for the treatment of alcohol use disorder using their lead investigational new drug product, AD04, a selective serotonin-3 antagonist.

Symbol

ADIL

Price Range
$5.00 - $5.00

Final Shares
1,500,000

Anticipated Date
TBD

Underwriters
Joseph Gunnar & Co.

To view the prospectus for Adial Pharmaceuticals IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253